ADVI Health’s Post

MedPro Systems is leading the way with #MCSR license solutions. If you are a pharmaceutical company with prescription products doing business in MA, this will impact you! Let us know if you need help or even if you just want to learn more. #MCSR #Compliance #prescription #controlledsubstances #medprosystems

“All of the drug industry’s criticisms and so-called 340B ‘reform proposals’ culminate in one goal, which is to limit the number of prescriptions available at 340B prices. This would inevitably prioritize drugmaker balance sheets over the clinical outcomes of vulnerable Americans.”   That’s from an editorial published by The Hill — one of three articles, from the last week alone, examining drug manufacturer restrictions and their impact on both 340B hospitals and the patients they serve. To learn more, read our blog summary of those articles. https://bit.ly/3sdP1dg   To learn how ProxsysRx has generated over $435M in 340B savings for the health systems we serve, despite manufacturer restrictions, contact Howard Hall. howard.hall@proxsysrx.com | 205.588.0946   #DrugsPharmaceuticals  #340B  #Savings  #Revenue

“All of the drug industry’s criticisms and so-called 340B ‘reform proposals’ culminate in one goal, which is to limit the number of prescriptions available at 340B prices. This would inevitably prioritize drugmaker balance sheets over the clinical outcomes of vulnerable Americans.”   That’s from an editorial published by The Hill — one of three articles, from the last week alone, examining drug manufacturer restrictions and their impact on both 340B hospitals and the patients they serve. To learn more, read our blog summary of those articles. https://bit.ly/3sdP1dg   To learn how ProxsysRx has generated over $435M in 340B savings for the health systems we serve, despite manufacturer restrictions, contact Howard Hall. howard.hall@proxsysrx.com | 205.588.0946   #DrugsPharmaceuticals #340B #Savings #Revenue

Are you feeling overwhelmed by the complex world of Medicare Part D drug plans? Don’t worry – Four Oaks Medicare Planning has you covered! In this informative and easy-to-follow video, Four Oaks Founder jamon White walks you through the essential aspects of Medicare Part D, how its prescription drug coverage works, how to choose the right Part D plan for you, and lots more! Don’t let confusion stand in the way of your Medicare decisions - watch our video below and get answers! https://hubs.li/Q025ljVc0 #FourOaksMedicarePlanning #MedicarePartD #MedicareOptions

Are you feeling overwhelmed by the complex world of Medicare Part D drug plans? Don’t worry – Four Oaks Medicare Planning has you covered! In this informative and easy-to-follow video, Four Oaks Founder jamon White walks you through the essential aspects of Medicare Part D, how its prescription drug coverage works, how to choose the right Part D plan for you, and lots more! Don’t let confusion stand in the way of your Medicare decisions - watch our video below and get answers! https://hubs.li/Q025lzZJ0 #FourOaksMedicarePlanning #MedicarePartD #MedicareOptions

🔍 Attention Healthcare Professionals: PBMs are significantly impacting prescription drug costs and transparency. This issue affects both patient care and taxpayer dollars. Learn about the latest legislative actions in Washington and how we can advocate for better practices.  #HealthcareTransparency #PBMs #PatientRights #IndependentPharmacy #SmallBusinessSupport #CommunityPharmacy #CompoundingPharmacy

Are you feeling overwhelmed by the complex world of Medicare Part D drug plans? Don’t worry – Four Oaks Medicare Planning has you covered! In this informative and easy-to-follow video, Four Oaks Founder jamon White walks you through the essential aspects of Medicare Part D, how its prescription drug coverage works, how to choose the right Part D plan for you, and lots more! Don’t let confusion stand in the way of your Medicare decisions - watch our video below and get answers! https://hubs.li/Q025lmFd0 #FourOaksMedicarePlanning #MedicarePartD #MedicareOptions

“It's like a balloon. When a squeeze inflates drug costs in one place, you have to reign them in somewhere else." So begins a recent HealthLeaders piece by Mandi Poplawski, VP of Pharmacy Management for CareFirst BlueCross BlueShield. She summaries the pressurized landscape of prescription drug costs in the U.S., the latest squeeze being the Inflation Reduction Act (IRA). Read how she believes the IRA is "the largest change to the Medicare Part D program since its inception in 2006," and how lower drug costs under the IRA will drive higher costs elsewhere -https://lnkd.in/eWdFRtNQ With change comes uncertainty. Reach out to us to learn how we can help quantify and optimize risk-sharing to improve market access - https://lnkd.in/eVF_4DBY #HEOR #IRA #DrugPricing 

Specialty drugs are a complex area of claims processing, with almost half of specialty drug claims occuring under a health plan's medical benefit rather than the pharmacy benefit. This complexity and expense make specialty drug claims prone to inaccurate billing, or worse, fraud, waste, and abuse. Watch our latest YouTube webinar for critical insights, including why relying solely on prior authorization can result in limited details that can leave plans open to inappropriate claims. Subscribe to our YouTube channel for more. https://bit.ly/3tR0vUF #HealthPlans #FWA #fraud

Join us on February 21st, for a webinar on navigating weight loss drug approvals and patient demands. Learn about the latest innovative medicines of, overcoming access barriers, navigating prior authorization claims, upcoming policy changes, and insights from CMS and AMA. Don't miss out on understanding the impact of the Inflation Reduction Act on Medicare drugs. Register now for invaluable insights: https://lnkd.in/etTG8N47 #weightloss #MedicineApprovals #PriorAuthorization #ACMAwebinars